Article Details

Clinical trial suggests convalescent plasma may improve survival with severe COVID-19

Retrieved on: 2021-05-17 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

Clinical trial suggests convalescent plasma may improve survival with severe COVID-19. View article details on hiswai:

Excerpt

A randomized double-blind controlled trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the ...

Article found on: www.miragenews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up